Log in
Enquire now
‌

US Patent 7659442 Method for making homozygous genetic modifications

Patent 7659442 was granted and assigned to Regeneron Pharmaceuticals, Inc. on February, 2010 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors
Is a
Patent
Patent
Date Filed
September 27, 2007
Date of Patent
February 9, 2010
Patent Application Number
11904558
Patent Citations Received
‌
US Patent 12127537 Genetically modified non-human animals and methods of use thereof
0
‌
US Patent 11889821 Enhanced immunoglobulin diversity
0
‌
US Patent 11910787 Rodents having a humanized TMPRSS gene
0
‌
US Patent 11957115 Genetically modified mouse expressing human APOE4 and mouse Trem2 p.R47H and methods of use thereof
0
‌
US Patent 11963521 Humanized IL-4 and IL-4Rα animals
0
‌
US Patent 12010979 Non-human animals comprising a humanized TTR locus and methods of use
0
‌
US Patent 12089576 Nucleic acids comprising a modified rodent activin a receptor type 1 (Acvr1) gene
0
‌
US Patent 12127536 Humanized M-CSF mice
0
‌
US Patent 11655286 Anti-PcrV antibodies that bind PcrV, compositions comprising anti-PcrV antibodies, and methods of use thereof
0
‌
US Patent 11696572 Non-human animals comprising a humanized ASGR1 locus
0
•••
Patent Inventor Names
David Frendewey
0
Thomas M. DeChiara
0
William Poueymirou
0
Wojtek Auerbach
0
David M. Valenzuela
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
7659442
Patent Primary Examiner
‌
Thaian N. Ton

Find more entities like US Patent 7659442 Method for making homozygous genetic modifications

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.